Exiqon公司属于QIAGENE集团，该公司在microRNA表达分析领域具有国际领先地位，于2005年获得了Ernst&Youngs生物类大奖。Exiqon公司提供miRCURY系列产品，专门用于研究microRNA的表达、分布和功能。Exiqon的microRNA芯片亲和力更高，使用基于LNA专利技术的捕获探针。

Exiqon's products and services are used by researchers in academia, biotech and pharmaceutical companies around the world to make groundbreaking discoveries about the correlation between gene activity and the development of disease. Taking advantage of our proprietary LNA™ technology, our product lines offer superior specificity and sensitivity for analysis of microRNA, mRNA and long non-coding RNA. Exiqon's products and services encompass the entire workflow from sample preparation to expression analysis (Sequencing, Array and qPCR), detection and functional analysis both in vitro and in vivo. Exiqon Services offers expertise in RNA Next Generation Sequencing, microRNA profiling and biomarker discovery from clinical samples.

Exiqon公司的主要产品包括：

microRNA products

mRNA & lncRNA products

Customer support

LNA™ oligos

RNA services

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Svar Life Science品牌。

Svar Life Science 是一家专注于生物技术和生命科学研究工具的公司，提供高质量的诊断试剂、抗体和生物分析工具，支持基础研究、临床诊断和药物开发。Svar Life Science采用先进的生产和质控技术，确保产品的高质量和一致性；产品广泛应用于基础研究、临床诊断和药物开发。应用领域包括：免疫学、细胞生物学和分子生物学研究；用于疾病诊断、生物标志物检测和健康监测；用于药物筛选、药效评估和毒性测试；用于生物制药、疫苗开发和生物材料研究。

Svar Life Science产品和服务包括：

（1）诊断试剂：提供多种用于临床诊断的试剂盒，包括免疫分析试剂盒和分子诊断试剂盒。

（2）抗体：提供多种高特异性和高灵敏度的抗体，用于免疫学研究和诊断。

（3）生物分析工具：提供多种生物分析工具，如ELISA试剂盒、蛋白质印迹试剂和细胞分析试剂。

（4）定制服务：根据客户需求，提供定制化的诊断试剂和抗体开发服务。

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.